Refinement of SARS-CoV-2 envelope protein structure in a native-like environment by molecular dynamics simulations

被引:6
|
作者
Yang, Rui [1 ]
Wu, Sijin [1 ]
Wang, Shen [1 ]
Rubino, Grace [2 ]
Nickels, Jonathan D. [3 ]
Cheng, Xiaolin [1 ,4 ]
机构
[1] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Engn, Dept Chem & Biomol Engn, Columbus, OH USA
[3] Univ Cincinnati, Dept Chem & Environm Engn, Cincinnati, OH 45221 USA
[4] Ohio State Univ, Translat Data Analyt Inst TDAI, Columbus, OH 43210 USA
关键词
COVID-19; coronavirus; envelope (E) protein; SARS-CoV-2; E protein inhibitors; RESPIRATORY SYNDROME CORONAVIRUS; PARAMETERS; SOFTWARE; STRATEGY; EWALD; IONS; GUI;
D O I
10.3389/fmolb.2022.1027223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
COVID-19 has become an unprecedented threat to human health. The SARS-CoV-2 envelope (E) protein plays a critical role in the viral maturation process and pathogenesis. Despite intensive investigation, its structure in physiological conditions remains mysterious: no high-resolution full-length structure is available and only an NMR structure of the transmembrane (TM) region has been determined. Here, we present a refined E protein structure, using molecular dynamics (MD) simulations to investigate its structure and dynamics in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer system. Our initial homology model based upon the SARS-CoV E protein structure is shown to be unstable in the lipid bilayer, and the H3 helices tend to move away from the membrane center to the membrane-water interface. A more stable model was developed by replacing all H3 helices with the fully equilibrated H3 structure sampled in the MD simulations. This refined model exhibited more favorable contacts with lipids and water than the original homology model and induced local membrane curvature, decreasing local lipid order. Interestingly, the pore radius profiles showed that the channel in both homology and refined models remained in a closed state throughout the simulations. We also demonstrated the utility of this structure to develop anti-SARS-CoV-2 drugs by docking a library of FDA-approved, investigational, and experimental drugs to the refined E protein structure, identifying 20 potential channel blockers. This highlights the power of MD simulations to refine low-resolution structures of membrane proteins in a native-like membrane environment, shedding light on the structural features of the E protein and providing a platform for the development of novel antiviral treatments.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations
    Masand, Vijay H.
    Sk, Md Fulbabu
    Kar, Parimal
    Rastija, Vesna
    Zaki, Magdi E. A.
    CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2021, 217
  • [32] Molecular Docking Analysis of Phytochemical Thymoquinone as a Therapeutic Agent on SARS-Cov-2 Envelope Protein
    Mohideen, Abdul Khader Sultan
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2021, 11 (01): : 8389 - 8401
  • [33] Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations
    Ahamad, Shahzaib
    Gupta, Dinesh
    Kumar, Vijay
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (06) : 2430 - 2443
  • [34] Computational Study on the Function of Palmitoylation on the Envelope Protein in SARS-CoV-2
    Sun, Shengjie
    Karki, Chitra
    Aguilera, Javier
    Hernandez, Alan E. Lopez
    Sun, Jianjun
    Li, Lin
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2021, 17 (10) : 6483 - 6490
  • [35] Membrane Condensation and Curvature Induced by SARS-CoV-2 Envelope Protein
    Woelk, Christian
    Shen, Chen
    Hause, Gerd
    Surya, Wahyu
    Torres, Jaume
    Harvey, Richard D.
    Bello, Gianluca
    LANGMUIR, 2024, 40 (05) : 2646 - 2655
  • [36] SARS-CoV-2 envelope protein regulates innate immune tolerance
    Geanes, Eric S.
    McLennan, Rebecca
    Pierce, Stephen H.
    Menden, Heather L.
    Paul, Oishi
    Sampath, Venkatesh
    Bradley, Todd
    ISCIENCE, 2024, 27 (06)
  • [37] Molecular Docking Studies of Curcumin Analogues against SARS-CoV-2 Spike Protein
    Nogueira, Jessica R.
    Verza, FlaviaA
    Nishimura, Felipe
    Das, Umashankar
    Caruso, Icaro P.
    Fachin, Ana L.
    Dimmock, Jonathan R.
    Marins, Mozart
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2021, 32 (10) : 1943 - 1955
  • [38] Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers
    Mandala, Venkata S.
    McKay, Matthew J.
    Shcherbakov, Alexander A.
    Dregni, Aurelio J.
    Kolocouris, Antonios
    Hong, Mei
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2020, 27 (12) : 1202 - U270
  • [39] An Immunoinformatics Study to Predict Epitopes in the Envelope Protein of SARS-CoV-2
    Jakhar, Renu
    Gakhar, S. K.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2020, 2020
  • [40] Evolution of Stronger SARS-CoV-2 Variants as Revealed Through the Lens of Molecular Dynamics Simulations
    Wozney, Alec J.
    Smith, Macey A.
    Abdrabbo, Mobeen
    Birch, Cole M.
    Cicigoi, Kelsey A.
    Dolan, Connor C.
    Gerzema, Audrey E. L.
    Hansen, Abby
    Henseler, Ethan J.
    LaBerge, Ben
    Leavens, Caterra M.
    Le, Christine N.
    Lindquist, Allison C.
    Ludwig, Rikaela K.
    O'Reilly, Maggie G.
    Reynolds, Jacob H.
    Sherman, Brandon A.
    Sillman, Hunter W.
    Smith, Michael A.
    Snortheim, Marissa J.
    Svaren, Levi M.
    Vanderpas, Emily C.
    Voon, Aidan
    Wackett, Miles J.
    Weiss, Moriah M.
    Hati, Sanchita
    Bhattacharyya, Sudeep
    PROTEIN JOURNAL, 2022, 41 (4-5) : 444 - 456